Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- 21 August 2018
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 11 (544)
- https://doi.org/10.1126/scisignal.aat6753
Abstract
Chimeric antigen receptors (CARs) link an antigen recognition domain to intracellular signaling domains to redirect T cell specificity and function. T cells expressing CARs with CD28/CD3ζ or 4-1BB/CD3ζ signaling domains are effective at treating refractory B cell malignancies but exhibit differences in effector function, clinical efficacy, and toxicity that are assumed to result from the activation of divergent signaling cascades. We analyzed stimulation-induced phosphorylation events in primary human CD8+ CD28/CD3ζ and 4-1BB/CD3ζ CAR T cells by mass spectrometry and found that both CAR constructs activated similar signaling intermediates. Stimulation of CD28/CD3ζ CARs activated faster and larger-magnitude changes in protein phosphorylation, which correlated with an effector T cell–like phenotype and function. In contrast, 4-1BB/CD3ζ CAR T cells preferentially expressed T cell memory–associated genes and exhibited sustained antitumor activity against established tumors in vivo. Mutagenesis of the CAR CD28 signaling domain demonstrated that the increased CD28/CD3ζ CAR signal intensity was partly related to constitutive association of Lck with this domain in CAR complexes. Our data show that CAR signaling pathways cannot be predicted solely by the domains used to construct the receptor and that signal strength is a key determinant of T cell fate. Thus, tailoring CAR design based on signal strength may lead to improved clinical efficacy and reduced toxicity.Keywords
Funding Information
- National Cancer Institute (CA136551)
- National Cancer Institute (CA114536)
- National Cancer Institute (CA214114)
- National Cancer Institute (CA211499)
- National Cancer Institute (CA080416)
- Fred Hutchinson Cancer Research Center (217155)
This publication has 68 references indexed in Scilit:
- Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapyNature Biotechnology, 2016
- Chimeric Antigen Receptor T Cells for Sustained Remissions in LeukemiaThe New England Journal of Medicine, 2014
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trialThe Lancet, 2014
- Dynamin related protein 1‐dependent mitochondrial fission regulates oxidative signalling in T cellsFEBS Letters, 2014
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genomeBMC Bioinformatics, 2011
- More than 100,000 Detectable Peptide Species Elute in Single Shotgun Proteomics Runs but the Majority is Inaccessible to Data-Dependent LC−MS/MSJournal of Proteome Research, 2011
- The mitochondrial fission factor dynamin-related protein 1 modulates T-cell receptor signalling at the immune synapseThe EMBO Journal, 2011
- Constitutively Active Lck Kinase in T Cells Drives Antigen Receptor Signal TransductionImmunity, 2010
- An Enigmatic Tail of CD28 SignalingCold Spring Harbor Perspectives in Biology, 2010
- A Scaffold Protein, AHNAK1, Is Required for Calcium Signaling during T Cell ActivationImmunity, 2008